Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNAH1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF862 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CASP8 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | EML2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SF3A2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | DUSP11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | JAM3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | RGPD5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | FOXN4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | THAP5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |